The US government granted Moderna $176 million to accelerate the development of an mRNA-based flu vaccine in response to mounting concerns about the H5N1 avian flu outbreak in dairy cows.
This money is significant because the virus spreads, and people fear a possible human pandemic.
(Photo: Getty Images/ Thomas Lhones)
Moderna's Work on mRNA Vaccines
The money passes through the Rapid Response Partnership Vehicle (RRPV) Consortium, which is run under the Biomedical Advanced Research and Development Authority (BARDA). By fostering alliances between companies to develop vital medical countermeasures, this program seeks to better equip the nation against pandemic threats.
Moderna has been working on mRNA solutions for different types of pandemic flu, such as H5 and H7. The company is known for developing new ways to vaccinate against COVID-19.
Last year, Moderna started Phase 1/2, testing a pandemic flu vaccination against H5 and H7 variants. The outcomes of this trial, which should be out shortly, will guide Phase 3 research, scheduled for 2025.
Stéphane Bancel of Moderna discussed the advantages of mRNA technology. He added that mRNA vaccine technologies assist in battling infectious disease outbreaks by being efficient, fast-developing, and producing many vaccinations simultaneously.
READ ALSO: Finland To Become the First Country in the World to Administer Bird Flu Vaccination for Humans
Government Response and Ongoing Challenges
The Department of Health and Human Services (HHS) has worked hard to stop H5N1 transmission. Dawn O'Connell, Assistant Secretary for Preparedness and Response, stressed that this funding helps the government respond quickly to flu strains and mutations. HHS and Pfizer are discussing a new bird flu mRNA vaccine.
The government is working harder than ever to make 4.8 million vials of the H5N1 flu vaccine in the next few months in response to the outbreak, which has hit more than 130 herds in 12 states. These vaccines could save farm workers and other people more likely to get sick.
Even with these steps, the US reaction has been criticized for taking too long to find and contain the virus. Genetic tests show that the virus has been spreading among dairy cows since the end of last year, but the first proven cases weren't found until March.
One big problem with controlling the spread is that farmers and farm workers don't want to work with health officials. Testing has been limited, and infected cattle are still moving around, which has made it harder to control the disease. Experts warn that the virus's spread among animals raises the chance that it will change, which could be passed from person to person.
Getting the US government and Moderna to work together is a big step toward dealing with the H5N1 danger. Creating an mRNA-based vaccine gives people hope that future pandemics can be dealt with more quickly and effectively.
As the world continues to deal with the difficulties of infectious disease attacks, this project shows how important it is to be ready to develop new ideas in public health. Keep up with the newest medical studies and healthcare developments to see how they can help stop pandemics in the future.
RELATED ARTICLE: Moderna's Combination Vaccine Against COVID-19 and Flu Sees Positive Result in Advance Trial; How Effective Is mRNA-1083 in Triggering Immune Response?
Check out more news and information on Vaccination in Science Times.
